Anne B. Jokilammi

Turku, Finland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Recurrent cancer-associated ERBB4 mutations are transforming and confer resistance to targeted therapies.

Recurrent cancer-associated ERBB4 mutations are transforming and confer resistance to targeted therapies.

Journal: Molecular oncology
Published: July 04, 2025

Phosphoproteomic analysis reveals the diversity of signaling behind ErbB-inhibitor-induced phenotypes.

Phosphoproteomic analysis reveals the diversity of signaling behind ErbB-inhibitor-induced phenotypes.

Journal: The FEBS journal
Published: July 30, 2024

Empagliflozin attenuates hypoxia-induced heart failure of zebrafish embryos via influencing MMP13 expression.

Empagliflozin attenuates hypoxia-induced heart failure of zebrafish embryos via influencing MMP13 expression.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 11, 2024

Immunomodulatory Synthetic Glycocluster Molecule Prevents Melanoma Growth In Vivo.

Immunomodulatory Synthetic Glycocluster Molecule Prevents Melanoma Growth In Vivo.

Journal: Chembiochem : a European journal of chemical biology
Published: March 21, 2024

STAT5b is a key effector of NRG-1/ERBB4-mediated myocardial growth.

STAT5b is a key effector of NRG-1/ERBB4-mediated myocardial growth.

Journal: EMBO reports
Published: December 18, 2022

Combined genetic and chemical screens indicate protective potential for EGFR inhibition to cardiomyocytes under hypoxia.

Combined genetic and chemical screens indicate protective potential for EGFR inhibition to cardiomyocytes under hypoxia.

Journal: Scientific reports
Published: April 12, 2021

Design of a Cytotoxic Neuroblastoma-Targeting Agent Using an Enzyme Acting on Polysialic Acid Fused to a Toxin.

Design of a Cytotoxic Neuroblastoma-Targeting Agent Using an Enzyme Acting on Polysialic Acid Fused to a Toxin.

Journal: Molecular cancer therapeutics
Published: December 02, 2020

An extracellular receptor tyrosine kinase motif orchestrating intracellular STAT activation.

An extracellular receptor tyrosine kinase motif orchestrating intracellular STAT activation.

Journal: Nature communications
Published: February 21, 2020

Decorin Expression in Human Vulva Carcinoma: Oncosuppressive Effect of Decorin cDNA Transduction on Carcinoma Cells.

Decorin Expression in Human Vulva Carcinoma: Oncosuppressive Effect of Decorin cDNA Transduction on Carcinoma Cells.

Journal: The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society
Published: April 23, 2019

Receptor tyrosine kinase profiling of ischemic heart identifies ROR1 as a potential therapeutic target.

Receptor tyrosine kinase profiling of ischemic heart identifies ROR1 as a potential therapeutic target.

Journal: BMC cardiovascular disorders
Published: May 29, 2018

Human Metaplastic Breast Carcinoma and Decorin.

Human Metaplastic Breast Carcinoma and Decorin.

Journal: Cancer microenvironment : official journal of the International Cancer Microenvironment Society
Published: December 22, 2016

Changes in polysialic acid expression on myeloid cells during differentiation and recruitment to sites of inflammation: role in phagocytosis.

Changes in polysialic acid expression on myeloid cells during differentiation and recruitment to sites of inflammation: role in phagocytosis.

Journal: Glycobiology
Published: May 29, 2014
Showing 1-12 of 15

Last Updated: 09/26/2026